Evaluation of high trough-to-peak ratio of perindopril in SHR

Clinical and Experimental Hypertension

Volumn 21, Issue 7, 1999, Pages 1223-1238

  Moriyama, Sachiko ^a   Ishigai, Yutaka ^a   Mori, Tomohiro ^a   Fukuzawa, Akiko ^a   Shibano, Toshiro ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

ACE inhibitor; Blood pressure; Perindopril; SHR; Trough to peak ratio

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; PERINDOPRIL; QUINAPRIL; TRANDOLAPRIL; INDOLE DERIVATIVE; ISOQUINOLINE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HYPERTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; ANIMAL; BLOOD PRESSURE; CIRCADIAN RHYTHM; COMPARATIVE STUDY; DRUG EFFECT; HEART RATE; LOCOMOTION; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; TELEMETRY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; ENALAPRIL; HEART RATE; HYPERTENSION; INDOLES; ISOQUINOLINES; LOCOMOTION; MALE; PERINDOPRIL; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; TELEMETRY; TETRAHYDROISOQUINOLINES;

EID: 0032589384     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969909052199     Document Type: Article

References (19)

1. Rose M and McMahon FG. Some problem with antihypertensive drug studies in the context of the new guidelines. Am J Hypertens. 1990;3:151-155.
2. Meredith PA and Elliott HL. FAD guidelines on trough peak ratios in the evaluation of antihypertensive agents. J Cardiovasc Pharmacol. 1994;12(suppl 5):S26-S30.
3. Brockway BP, Mills PA and Azar SH. A new method for continuous chronic measurement and recording of blood pressure heart rate and activity in the rat via radio-telemetry. Clin. and Exper. Hyper-Theory and Practice. 1991;A13(5):885-895.
4. Salvetti A. Angiotensin converting enzyme inhibitors in the treatment of mild to moderate essential hypertension. Am J Hypertens. 1989;2:S94-S99.
5. Macfayden RJ, Lees KR and Reid JL. Perindopril : a review of its pharmacokinetics and clinical pharmacology. Drugs. 1990;39:49-63.
6. Myers MG. A dose-response study of perindopril in hypertension : Effects on blood pressure 6 and 24 h after dosing. Can J Cardiol. 1996;12:1191-1196.
7. Zannad F, Matzinger A and Larche J. Trough peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists. Am J Hypertens. 1996;9:633-643.
8. Zanchetti A. Trough : peak ratio of the blood pressure response to dihydropyridine calcium antagonists. J Hypertens. 1994;12:S97-S106.
9. Lemmer B, Mattes A, Bohm M, Ganten D. Circadian blood pressure variation in transgenic hypertensive rats. Hypertension. 1993;22:97-101.
10. Pickering TG. The clinical significance of diurnal blood pressure variations. 1990;81:700-702.
11. Elliott HL. Trough peak ratio and twenty-four-hour blood pressure control. J Hypertens. 1994;12:S29-S33.
12. Leonetti G and Cuspidi C. Choosing the right ACE inhibitor. Drugs. 1995;49:516-535.
13. Morgan T and Anderson A. Clinical efficiency of perindopril in hypertension. Clin Exp Pharmacol Physiol. 1992; 19:61-65.
14. The Veratran Study Group. Effect of Verapamil SR, Trandolapril, and their fixed combination on 24-h blood pressure. Am J Hypertens. 1997;10:492-499.
15. Morgan TO, Morgan O and Anderson A. Effect of dose on trough peak ratio of antihypertensive drugs in elderly hypertensive males. Clin and Exp Pharmacol and Physiology. 1995;22:778-780.
16. DiNicolantonio R and Doyle AE. Comparison of the action of angiotensin-converting enzyme inhibitors enalapril and S-9490-3 in sodium-deplete and sodium-replete spontaneously hypertensive rats. J Caldiovasc Pharmacol 1985; 7: 937-942.
17. Brown NL, Badel MY, Benzoni F, et al Angiotensin-converting enzyme inhibition, anti-hypertensive activity and hemodynamic profile of trandolapril (RU 44570). J Caldiovasc Pharmacol 1988; 148: 79-91.
18. Kaplan HR, Taylor DG and Olson SC. Quinapril: overview of preclinical data. Clin Cardiol 1990; 13 VII6-VII-12.
19. Sweet CS, Arbegast PT, Gaul SL, et al Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rat. European J Pharmacol 1981; 76: 167-176.